 |
Home
 Case Studies in Allergic Rhinitis: Focus on Nonprescription
Antihistamines
To obtain continuing
education credit for this program, participants must complete the
online program evaluation form by July 31, 2008.
Note: You will need your Pharmacist.com username and
password to register for the webinar and take the test for CE
credit. If you do not have a Pharmacist.com username and
password, create one now.
Allergic rhinitis is one of the most common chronic conditions in the
United States, and one for which patients frequently seek
self-treatment. The increasing nonprescription availability of
antihistamines means that more patients than ever may be able to
self-treat their symptoms successfully. Pharmacists can help to
ensure successful self-treatment by identifying appropriate patients and
assisting with product selection. Using a case-based approach, this
webinar will acquaint pharmacists with common patient scenarios and
highlight the optimal use of nonprescription antihistamines.
Learning Objectives
-
After participating in this webinar, pharmacists will be able
to:
-
Differentiate allergic rhinitis from other common upper respiratory
conditions.
-
Describe a novel classification system for allergic rhinitis that
is based on both duration and severity of symptoms.
-
Outline a stepwise approach to the treatment of allergic
rhinitis.
-
Determine whether a patient with allergic rhinitis is an
appropriate candidate for self-treatment.
-
Discuss the optimal use of nonprescription antihistamines in the
treatment of allergic rhinitis.
Speakers
Maria Marzella Sulli, PharmD
Associate Clinical Professor
St. John’s University
College of Pharmacy and Allied Health Professions
Queens, New York
Wellness Coordinator
King Kullen Pharmacy Wellness Place
Levittown, New York
Dennis M. Williams, PharmD
Associate Professor
University of North Carolina
School of Pharmacy
Chapel Hill, North Carolina
Financial Disclosures
Maria Marzella Sulli, PharmD, has served as a
consultant for GlaxoSmithKline and has been a grant recipient from
GlaxoSmithKline and Procter & Gamble.
Dennis M. Williams, PharmD, has served on an
advisory board for sanofi-aventis.
APhA’s editorial staff declares no conflicts
of interest or financial interests in any product or service mentioned
in this program, including grants, employment, gifts, stock holdings,
and honoraria.
CE Credit
 The American Pharmacists Association
is accredited by the Accreditation Council for Pharmacy Education as a
provider of continuing pharmacy education. This program, Case
Studies in Allergic Rhinitis: Focus on Nonprescription Antihistamines,
ACPE #202-000-08-106-L01-P, is approved for 2 hours of continuing
education credit (0.2 CEUs). There is no fee to participate in this
activity.
To obtain continuing education credit for this program, participants
must pre-register online (limited to 200 seats), participate in the
entire program, and complete the online program evaluation form by
July 31, 2008. A Statement of Credit will be
automatically generated upon achieving these requirements.
Participants can obtain continuing education credit for only one of the
five offerings of this webinar.
If you attended this symposium, Case Studies in Allergic
Rhinitis: Focus on Nonprescription Antihistamines (ACPE
#202-000-08-106-L01-P), on March 15, 2008 at the APhA2008 Annual Meeting
in San Diego, California and received CE credit, you are not eligible
for additional credit.
Initial Release Date: March 15, 2008
This webinar was developed by the American Pharmacists Association
and supported through an educational grant from McNeil Consumer
Healthcare.
 
|
